Skip to search formSkip to main contentSkip to account menu

JTV-803

Known as: JTV 803, JTV803 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Heterogeneity of synthetic factor Xa inhibitors.
Heparins and vitamin K antagonists are the landmarks of antithrombotic treatment. Both of them were discovered by serendipity… 
2004
2004
Synthetic Anti-Xa Drugs Can Be Used for Parenteral Anticoagulation but Not Fondaparinux.
Targeting at the level of factor Xa and/or prothrombinase complex by synthetic anti-Xa agents such as JTV-803 (Akros Pharma… 
2002
2002
Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models
We examined whether JTV-803, a specific activated factor X inhibitor independent of antithrombin III (ATIII), is effective… 
2001
2001
Antithrombotic effects of a synthetic inhibitor of activated factor X, JTV-803, in animals.
2001
2001
Inhibitory effect of JTV-803, a new cyclic guanidine derivative, on factor Xa in vitro and in vivo.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)